ALLIANCEBERNSTEIN L.P. - KEROS THERAPEUTICS INC ownership

KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 129 filers reported holding KEROS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of KEROS THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$6,876,113
+13.1%
150,462
+63.8%
0.00%0.0%
Q1 2024$6,081,000
+624.2%
91,858
+334.9%
0.00%
Q4 2023$839,731
+24.7%
21,1200.0%0.00%
Q3 2023$673,306
-20.7%
21,1200.0%0.00%
Q2 2023$848,602
+21.9%
21,120
+29.6%
0.00%
Q1 2023$696,010
-11.1%
16,3000.0%0.00%
Q4 2022$782,726
+39.5%
16,300
+9.4%
0.00%
Q3 2022$561,000
+35.5%
14,900
-0.7%
0.00%
Q2 2022$414,000
-37.6%
15,000
+23.0%
0.00%
Q1 2022$663,000
-7.1%
12,2000.0%0.00%
Q4 2021$714,000
+19.6%
12,200
-19.2%
0.00%
Q3 2021$597,000
-6.9%
15,1000.0%0.00%
Q2 2021$641,000
-23.4%
15,100
+11.0%
0.00%
Q1 2021$837,000
-18.2%
13,600
-6.2%
0.00%
Q4 2020$1,023,000
+278.9%
14,500
+107.1%
0.00%
Q3 2020$270,000
+17.9%
7,000
+14.8%
0.00%
Q2 2020$229,0006,1000.00%
Other shareholders
KEROS THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 276,000$7,626,0003.44%
First Light Asset Management, LLC 598,333$16,532,0001.92%
Fairmount Funds Management LLC 272,498$7,529,0001.72%
Deep Track Capital, LP 739,528$20,433,0001.34%
Nantahala Capital Management 911,901$25,196,0001.26%
Octagon Capital Advisors LP 152,249$4,207,0001.12%
CHI Advisors LLC 103,429$2,858,0001.09%
Altium Capital Management LP 88,000$2,431,0000.97%
Orbimed Advisors 1,679,417$46,402,0000.84%
Parkman Healthcare Partners LLC 47,788$1,320,0000.49%
View complete list of KEROS THERAPEUTICS INC shareholders